Gallic aldehyde
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Gallic aldehyde
Description :
Gallic aldehyde (3,4,5-Trihydroxybenzaldehyde) is a phenolic aldehyde. Gallic aldehyde can be isolated from Geum japonicum. Gallic aldehyde inhibits the gelatinolytic activity and expression of MMP-9. Gallic aldehyde also inhibits ERK1/2, p38, and JNK. Gallic aldehyde has potent anti-HSV-1 and antioxidant activities. Gallic aldehyde also exhibits antibacterial activity against Oenococcus oeni VF[1][2][3][4].UNSPSC :
12352005Hazard Statement :
H302, H315, H319, H335Target :
ERK; HSV; JNK; MMP; p38 MAPKType :
Reference compoundRelated Pathways :
Anti-infection; MAPK/ERK Pathway; Metabolic Enzyme/Protease; Stem Cell/WntApplications :
COVID-19-anti-virusField of Research :
InfectionAssay Protocol :
https://www.medchemexpress.com/gallic-aldehyde.htmlPurity :
99.95Solubility :
DMSO : 116.67 mg/mL (ultrasonic)Smiles :
O=CC1=CC(O)=C(O)C(O)=C1Molecular Formula :
C7H6O4Molecular Weight :
154.12Precautions :
H302, H315, H319, H335References & Citations :
[1]Kadota S, et al. A New Hydrolyzable Tannin from Geum japonicum and Its Antiviral Activity[J]. Heterocycles, 1994, 38 (1) :167-175.|[2]Miwa H, et al. Liquid chromatographic determination of free and total fatty acids in milk and milk products as their 2-nitrophenylhydrazides. J Chromatogr. 1990 Dec 7;523:235-46. |[3]Thomas SC, et al. Phytotoxicity and hormesis in common mobile organic compounds in leachates of wood-derived biochars. Biochar. 2024;6 (1) :51. |[4]Arturo Anadon, et al. EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) ; Scientific Opinion on Flavouring Group Evaluation 06, Revision 2 (FGE.06Rev2) : Straight- and branched-chain aliphatic unsaturated primary alcohols, aldehydes, carboxylic acids, and esters from chemical groups 1 and 4. EFSA Journal 2011; 9 (3) :1844. [78 pp.].Shipping Conditions :
Room TemperatureStorage Conditions :
4°C (Powder, stored under nitrogen)Scientific Category :
Reference compound1Clinical Information :
No Development ReportedIsoform :
ERK1; ERK2; MMP-9CAS Number :
[13677-79-7]

